Patient
Information
NEUROENDOCRINE CANCER
The NETest 2.0®
The NETest 2.0® is a simple and rapid blood test that can be used by clinicians to:
- Aid in diagnosis
- Predict tumor progression
- Predict response to therapeutics
- Monitor disease recurrence
Discuss with your doctor if NETest 2.0® can help with your disease journey.
PRRT
NETest PPQ 2.0®
This test predicts the likelihood of patient response to peptide receptor radionuclide therapy (PRRT) with 96% accuracy.
Discuss with your doctor if NETest PPQ® can help with your disease journey.
PROSTATE CANCER
PROSTest®
PROSTest® is a non-invasive blood test with over 90% accuracy in detecting prostate cancer that can be used by clinicians to:
- Aid in diagnosis
- Predict tumor progression
- Predict response to therapeutics
- Monitor disease recurrence
Discuss with your doctor if PROSTest® can help with your disease journey.
PROVEN PERFORMANCE
Why Choose Our Diagnostics?
Non-Invasive
Unlike a tissue biopsy, which relies on harvested tissue, our diagnostics are based on a drop of blood or saliva.
Highly Accurate
Our peer-reviewed research proves that mRNA is unsurpassed for testing accuracy, which means early detection and a correct diagnosis.
Tried and True
Our methods are backed by over 60 scientific studies and have been widely used by leading doctors and over 10,000 patients.
